• 2009 September 01

Company Description

Perseid Therapeutics LLC was founded in September 2009 as a joint venture between Maxygen, Inc.

Perseid Therapeutics LLC was founded in September 2009 as a joint venture between Maxygen, Inc. and Astellas Pharma Inc. to co-develop Maxygen's technology assets in protein pharmaceuticals, including MAXY-4, a next-generation CTLA4-Ig. Under the terms of the agreement, Astellas received worldwide rights to commercialize MAXY-4 for autoimmune disease and transplantation.

  • Manufacturer:

    Science and Engineering
  • Formed:

    September 1, 2009
  • Company Website:

  • Company E-mail:

  • Company Address:

    515 Galveston Drive
    Redwood City, CA
    United States
  • CEO:

    • Grant Yonehiro
  • We recognize our sponsors starting at $1 per entry.
    Learn more at https://www.ithistory.org/benefits